Life Scientist > Biotechnology

Australia urged to join the growing MTP sector

06 April, 2017

According to a new report by CSIRO, medical technologies and pharmaceuticals (MTP) could add billions of dollars and thousands of jobs to the Australian economy within the next eight years.


Anti-inflammatory drug could slow motor neuron disease

29 March, 2017

Researchers have shown that the anti-inflammatory drug PMX205 is effective in animals with amyotrophic lateral sclerosis (ALS), in a breakthrough which could see the drug taken to human trials as early as 2019.


How to heal a broken heart

28 March, 2017 by Lauren Davis

US scientists have identified a drug candidate to restore heart muscle function following a heart attack, in a breakthrough which has been described as a game changer for people living with heart disease.


What's my age again?

24 March, 2017 by Adam Florance

Researchers are just six months away from human trials of a new drug that appears to repair damaged DNA, reversing the effects of radiation and ageing.


Spider protein could protect against stroke damage

21 March, 2017

Researchers have discovered a small protein in funnel web spider venom that could protect the brain from stroke-induced injury.


The tell-tale heart: 'beating' human heart muscle created from stem cells

17 March, 2017

Scientists have created a functional 'beating' human heart muscle from stem cells, in a breakthrough that will enable them to study cardiac biology and diseases 'in a dish'.


An alternative to antibiotics for CF patients

15 March, 2017

UK scientists have shown that bacteriophage (phage) therapy could offer a safe and effective alternative to antibiotics in the treatment of cystic fibrosis (CF) lung infections.


Pest rabbits succumbing to Korean calicivirus

14 March, 2017

CSIRO scientists have confirmed the first pest rabbit that has succumbed to the Korean strain of calicivirus, known as RHDV1 K5.


Tackling tuberculosis with garden dirt

02 March, 2017 by Adam Florance

Tuberculosis may seem like a disease of yesteryear, but new drug-resistant strains of Mycobacterium tuberculosis are on the rise.


3D-printed sternum successfully implanted

28 February, 2017

A collaboration between CSIRO, Anatomics and British doctors has resulted in the world's first implementation of a 3D-printed titanium and polymer sternum into a patient.


Medicinal cannabis access fast-tracked for Australian patients

22 February, 2017 by Lauren Davis

The Turbull government will facilitate faster access by qualified doctors to medicinal cannabis for approved patients.


Alzheimer's drug trial abandoned due to lack of efficacy

16 February, 2017 by Lauren Davis

Pharmaceutical company MSD has ended its phase 2/3 study evaluating the drug verubecestat in patients with mild to moderate forms of Alzheimer's disease (AD).


Breakthrough in treating diabetic kidney disease

13 February, 2017

Researchers have prevented the progression of diabetic kidney disease (DKD) in laboratory studies of type 2 diabetes, signalling an important breakthrough in the field of diabetes research.


Ebola treatment developed from horse antibodies

08 February, 2017

Antibodies sourced from horses could be used as part of post-exposure treatment in the next Ebola outbreak, according to an international research team.


Accelerated HIV reduction in animal trial

07 February, 2017

Biotron has completed its HIV-1 animal trial of drug candidate BIT225, announcing positive results which caused the company's share prices to rise by almost 15%.


  • All content Copyright © 2025 Westwick-Farrow Pty Ltd